Schonfeld Strategic Advisors LLC Lexicon Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 571,492 shares of LXRX stock, worth $1.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
571,492
Previous 960,150
40.48%
Holding current value
$1.11 Million
Previous $2.3 Million
58.33%
% of portfolio
0.01%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding LXRX
# of Institutions
130Shares Held
240MCall Options Held
617KPut Options Held
286K-
Artal Group S.A. Luxembourg, N4175MShares$340 Million18.64% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$19.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.29MShares$16.1 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.68MShares$14.9 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.85MShares$11.3 Million0.24% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $366M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...